Nutrition in Clinical Practice

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lipkin, A. C.
Right arrow Articles by Dickson, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lipkin, A. C.
Right arrow Articles by Dickson, B. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Nutrition in Clinical Practice, Vol. 20, No. 4, 423-439 (2005)
DOI: 10.1177/0115426505020004423

Invited Reviews

Nutrition Issues in Hematopoietic Stem Cell Transplantation: State of the Art

Ann Connell Lipkin, MS, RD*, Polly Lenssen, MS, RD* and Barbara J. Dickson, RD, MS{dagger}

* Children's Hospital and Regional Medical Centers, Seattle, Washington; and {dagger} VA Puget Sound Health Care System Seattle, Washington

Correspondence: Children's Hospital and Regional Medical Centers, PO Box 5371, M2-10 4800 Sandpoint Way NE, Seattle, WA 98105-0371. Electronic mail may be sent to ann.lipkin{at}seattlechildrens.org.

There have been many changes in hematopoietic stem cell transplantation (HSCT) that affect the patient's nutrition support. In the early 1970s, allogeneic transplants were the most common types of HSCTs; today, autologous transplants are the most common. Bone marrow, peripheral blood, and umbilical cord blood all now serve as sources of stem cells. Conditioning therapies include myeloablative, reduced-intensity myeloablative, and nonmyeloablative regimens. New medications are being developed and used to minimize the toxicities of the conditioning therapy and to minimize infectious complications. Supportive therapies for renal and liver complications have changed. In the past, HSCT patients received parenteral nutrition (PN) throughout their hospitalization and sometimes as home therapy. Because of medical complications and cost issues associated with PN, many centers are now working to use less PN and increase use of enteral nutrition. The immunosuppressed diet has changed from a sterile diet prepared under laminar-flow hoods to a more liberal diet that avoids high-risk foods and emphasizes safety in food handling practices. This article will review these changes in HSCT and the impact of these changes on the nutrition support of the patient.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Nutr Clin PractHome page
J. L. Thompson and J. Duffy
Nutrition Support Challenges in Hematopoietic Stem Cell Transplant Patients
Nutr Clin Pract, October 1, 2008; 23(5): 533 - 546.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
C. Doyle, L. H. Kushi, T. Byers, K. S. Courneya, W. Demark-Wahnefried, B. Grant, A. McTiernan, C. L. Rock, C. Thompson, T. Gansler, et al.
Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices
CA Cancer J Clin, November 1, 2006; 56(6): 323 - 353.
[Abstract] [Full Text] [PDF]